NO20033898L - Dimeriske isoflavoner - Google Patents

Dimeriske isoflavoner

Info

Publication number: NO20033898L
Authority: NO; Norway
Prior art keywords: isoflavones; dimeric; dimeric isoflavones
Prior art date: 2001-03-08

Application number

NO20033898A

Other languages

English (en)

Norwegian (no)

Other versions

NO20033898D0 (no

Inventor

Andrew Heaton

Naresh Kumar

Graham Edmund Kelly

Original Assignee

Novogen Res Pty Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-03-08

Filing date

2003-09-03

Publication date

2003-10-30

2003-09-03 Application filed by Novogen Res Pty Ltd filed Critical Novogen Res Pty Ltd

2003-09-03 Publication of NO20033898D0 publication Critical patent/NO20033898D0/no

2003-10-30 Publication of NO20033898L publication Critical patent/NO20033898L/no

Links

CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 title 1
150000002515 isoflavone derivatives Chemical class 0.000 title 1
235000008696 isoflavones Nutrition 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/34—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
- C07D311/38—2,3-Dihydro derivatives, e.g. isoflavanones

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Physical Education & Sports Medicine (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Dermatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Diabetes (AREA)
Rheumatology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Ophthalmology & Optometry (AREA)
Hematology (AREA)
Immunology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Psychology (AREA)
Urology & Nephrology (AREA)
Toxicology (AREA)
Emergency Medicine (AREA)
Biochemistry (AREA)
Oncology (AREA)
Obesity (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Gastroenterology & Hepatology (AREA)

NO20033898A 2001-03-08 2003-09-03 Dimeriske isoflavoner NO20033898L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
AUPR3633A AUPR363301A0 (en)	2001-03-08	2001-03-08	Dimeric isoflavones
PCT/AU2002/000264 WO2002070502A1 (en)	2001-03-08	2002-03-08	Dimeric isoflavones

Publications (2)

Publication Number	Publication Date
NO20033898D0 NO20033898D0 (no)	2003-09-03
NO20033898L true NO20033898L (no)	2003-10-30

Family

ID=3827642

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20033898A NO20033898L (no)	2001-03-08	2003-09-03	Dimeriske isoflavoner

Country Status (14)

Country	Link
US (1)	US7312344B2 (cs)
EP (1)	EP1373242A4 (cs)
JP (1)	JP2004529900A (cs)
CN (1)	CN100436439C (cs)
AU (1)	AUPR363301A0 (cs)
BR (1)	BR0208053A (cs)
CA (1)	CA2440642A1 (cs)
CZ (1)	CZ20032396A3 (cs)
HU (1)	HUP0303463A3 (cs)
IL (2)	IL157750A0 (cs)
MX (1)	MXPA03008076A (cs)
NO (1)	NO20033898L (cs)
NZ (1)	NZ528067A (cs)
WO (1)	WO2002070502A1 (cs)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0656786B2 (en) *	1992-05-19	2014-04-23	Novogen Research Pty Ltd	Use of isoflavone phyto-oestrogen extracts of soy or clover
EP0979074A4 (en) *	1997-05-01	2003-07-09	Novogen Inc	TREATMENT OR PREVENTION CLIMATE ACTION SYMPTOMS AND OSTEOPOROSIS
AUPP112497A0 (en) *	1997-12-24	1998-01-22	Novogen Research Pty Ltd	Compositions and method for protecting skin from UV induced immunosupression and skin damage
AUPQ520300A0 (en) *	2000-01-21	2000-02-17	Novogen Research Pty Ltd	Food product and process
AUPR363301A0 (en)	2001-03-08	2001-04-05	Novogen Research Pty Ltd	Dimeric isoflavones
EP1542654A4 (en) *	2002-09-23	2008-12-17	Novogen Res Pty Ltd	TREATMENT OF PHOTOTATIOOD AND ACTINIC DETERIORATION OF THE SKIN
US20040087527A1 (en) *	2002-10-31	2004-05-06	Day Brian J.	Methods for treatment of thiol-containing compound deficient conditions
US7790762B2 (en)	2002-10-31	2010-09-07	National Jewish Health	Compounds and methods for thiol-containing compound efflux and cancer treatment
JP5143993B2 (ja) *	2003-03-26	2013-02-13	株式会社産学連携機構九州	エストロゲン様活性剤
JP4668553B2 (ja) *	2004-05-27	2011-04-13	サントリーホールディングス株式会社	リパーゼ阻害活性および／または抗酸化活性を有するエピガロカテキン二量体および三量体
NZ561574A (en) *	2005-03-24	2010-03-26	Novogen Res Pty Ltd	Anti-inflammatory modalities for use against pain, oedema, and erythema (benzotetrahydropyrans, benzopyran derivatives, isoflavonoid derivatives)
EP1961309A4 (en) *	2005-12-06	2010-01-20	Otsuka Pharma Co Ltd	EMBRYONIC AXIS FERMENTATION PRODUCT OF SOYBEAN CONTAINING EQUOL, AND METHOD FOR PRODUCING THE SAME
BRPI0708361A2 (pt) *	2006-02-28	2011-05-24	Nestec S.A	composições e métodos para a indução de crescimento ósseo e para a inibição de perda óssea
JP5172913B2 (ja) *	2010-09-03	2013-03-27	サントリーホールディングス株式会社	リパーゼ阻害活性および／または抗酸化活性を有するエピガロカテキン二量体および三量体
CA3058503A1 (en)	2016-04-06	2017-10-12	Noxopharm Limited	Isoflavonoid composition with improved pharmacokinetics
CA3058492A1 (en) *	2016-04-06	2017-10-12	Noxopharm Limited	Radiotherapy improvements
WO2019051562A1 (en) *	2017-09-15	2019-03-21	Norbio No. 1 Pty Ltd	TREATMENT OF EXCITOTOXICITY
CN109985055B (zh) *	2019-04-03	2021-07-09	广州中医药大学(广州中医药研究院)	一种抗脑缺血再灌注损伤的药物组合物及其应用
EP4125870A1 (en)	2020-03-30	2023-02-08	Noxopharm Limited	Methods for the treatment of inflammation associated with infection
WO2023107507A1 (en) *	2021-12-06	2023-06-15	University Of Kentucky Research Foundation	Diaminobutoxy-substituted isoflavonoids as mitochondrial complex i inhibitors for cancer treatment

Family Cites Families (105)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1518002C3 (de) *	1965-01-02	1975-01-23	Merck Patent Gmbh, 6100 Darmstadt	Isoflavane und Isoflavene und Verfahren zu Ihrer Herstellung sowie diese enthaltende Arzneimittel
DE1543749A1 (de) *	1966-02-16	1969-12-11	Merck Ag E	Verfahren zur Herstellung von 3,4-cis-4-Aryl-isoflavanen
JPS54734B2 (cs)	1973-05-14	1979-01-16
US3973608A (en) *	1973-08-01	1976-08-10	Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai	Microbial production of certain isoflavones
JPS576427B2 (cs)	1974-01-25	1982-02-04
HU168753B (cs)	1974-05-03	1976-07-28
JPS50160483A (cs)	1974-06-19	1975-12-25
GB1495189A (en)	1975-09-12	1977-12-14	Pfizer Ltd	4-oxo-4h-benzopyran derivatives and process for their preparation
DE2643800C2 (de) *	1976-09-29	1986-10-30	Fritz Werner Industrie-Ausrüstungen GmbH, 6222 Geisenheim	Verfahren zur Herstellung von Xylose durch enzymatische Hydrolyse von Xylanen
US4157984A (en) *	1977-06-08	1979-06-12	Z-L Limited	Antioxidants, antioxidant compositions and methods of preparing and using same
US4264509A (en) *	1977-06-08	1981-04-28	Z-L Limited Partnership	Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
SU907060A1 (ru) *	1979-02-07	1982-02-23	Всесоюзный Научно-Исследовательский Биотехнический Институт	Способ получени розового масла
US4390559A (en) *	1979-04-11	1983-06-28	Z-L Limited Partnership	Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
US4366082A (en) *	1979-04-11	1982-12-28	Z-L Limited Partnership	Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
JPS5933232A (ja) *	1982-08-19	1984-02-23	Tokiwa Kanpou Seiyaku:Kk	マメ科植物からサポニン類およびフラボン類の分離方法
JPS59199630A (ja)	1983-04-26	1984-11-12	Takeda Chem Ind Ltd	卵巣機能低下症治療剤
JPS6048924A (ja)	1983-08-24	1985-03-16	Takeda Chem Ind Ltd	骨粗鬆症治療剤
JPS6054379A (ja)	1983-09-05	1985-03-28	Takeda Chem Ind Ltd	新規４ｈ−１−ベンゾピラン−４−オン誘導体，その製法および用途
JPS61246124A (ja)	1985-04-24	1986-11-01	Yamanouchi Pharmaceut Co Ltd	制癌剤
JPS61247396A (ja)	1985-04-24	1986-11-04	Yamanouchi Pharmaceut Co Ltd	ゲニステインの製造法
JPS62106016A (ja)	1985-11-01	1987-05-16	Yamanouchi Pharmaceut Co Ltd	免疫抑制剤
JPS62106017A (ja)	1985-11-01	1987-05-16	Yamanouchi Pharmaceut Co Ltd	抗腫瘍剤
JPS62126186A (ja)	1985-11-28	1987-06-08	Tsumura Juntendo Inc	イソフラボン誘導体含有溶液の製造方法
GB8626344D0 (en) *	1986-11-04	1986-12-03	Zyma Sa	Bicyclic compounds
JPS6442427A (en)	1987-08-10	1989-02-14	Tsumura & Co	Sialidase inhibitor
JPH0832632B2 (ja)	1988-03-08	1996-03-29	株式会社太田胃散	尿素窒素代謝改善剤
JPH0714927B2 (ja)	1988-04-06	1995-02-22	キッコーマン株式会社	イソフラボン化合物の製造法
JPH0267218A (ja)	1988-08-31	1990-03-07	Nagakura Seiyaku Kk	ウイルス・ゲノム不活化剤
JPH0269165A (ja)	1988-09-02	1990-03-08	Mitsugi Ohashi	癌抑制食品
JPH02124883A (ja)	1988-11-04	1990-05-14	Kitasato Inst:The	抗酸化作用を有するイソフラボン誘導体およびその製造法
JP2753719B2 (ja)	1988-12-15	1998-05-20	日本油脂株式会社	リポソーム製剤の製造法
JPH0347049A (ja)	1989-03-09	1991-02-28	Sanyu:Kk	豆腐廃液ゆからの食品素材及び健康飲料の製造方法
US5153230A (en) *	1989-10-06	1992-10-06	Perfective Cosmetics, Inc.	Topical skin cream composition
CH679584A5 (cs)	1989-11-10	1992-03-13	Nestle Sa
IT1241079B (it)	1990-03-23	1993-12-29	Chiesi Farma Spa	Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico
JPH089610B2 (ja) *	1990-04-06	1996-01-31	キノイン・ジョージセル・エーシュ・ヴェジェーセティ・テルメーケク・ジャーラ・エルテー	置換イソフラボン誘導体の改良された製造方法
GB2261671B (en) *	1991-11-16	1996-07-03	Gb Biotech	Gel production from plant matter
JPH05170756A (ja)	1991-12-20	1993-07-09	Kikkoman Corp	イソフラボン化合物の製造法
EP0656786B2 (en) *	1992-05-19	2014-04-23	Novogen Research Pty Ltd	Use of isoflavone phyto-oestrogen extracts of soy or clover
FR2693724B1 (fr)	1992-07-17	1994-10-07	Lipha	Utilisation de composés benzopyraniques ou benzothiopyraniques pour l'induction de l'expression des gènes de la nodulation des bactéries du genre Rhizobium associées aux légumineuses.
JPH0640909A (ja)	1992-07-23	1994-02-15	Kobe Steel Ltd	スーパーオキシド・ディスムターゼ様活性剤
JPH0686682A (ja)	1992-07-23	1994-03-29	Kobe Steel Ltd	４’，７，８−トリヒドロキシイソフラボンの製造方法
JPH0640876A (ja)	1992-07-23	1994-02-15	Kobe Steel Ltd	紫外線障害防御外用剤
WO1994023716A1 (en)	1993-04-16	1994-10-27	Tufts University School Of Medicine	Method for treatment of menopausal and premenstrual symptoms
JPH06321752A (ja)	1993-05-07	1994-11-22	Kao Corp	美白剤
HUT68558A (en)	1993-07-20	1995-06-28	Chinoin Gyogyszer Es Vegyeszet	Method for preparing isoflavon derivatives
CA2173743A1 (en) *	1993-10-12	1995-04-20	Jerome L. Shen	An aglucone isoflavone enriched vegetable protein extract and isolate and process for producing
US5320949A (en) *	1993-10-12	1994-06-14	Protein Technologies International, Inc.	Process for producing aglucone isoflavone enriched vegetable protein fiber
BR9407822A (pt) *	1993-10-12	1997-05-06	Protein Tech Int	Processo para produção de um soro de leite coalhado de proteina vegetal enriquecido com aglucono isoflavona soro de leite coalhado enriquecido com aglucono isoflavona proteina de soro de leite coalhado enriquecido com aglucono isoflavona e processo para a recuperação em uma proteina de leite coalhado de pelo mones 50% de uma isoflavona de um material de proteina vegetal
JP3078694B2 (ja)	1993-12-17	2000-08-21	キッコーマン株式会社	ゲニステインの製造法
IL112061A (en) *	1994-01-13	1999-10-28	Bristol Myers Squibb Co	Methods for the preparation of taxanes
US6369103B1 (en)	1994-01-18	2002-04-09	Bristol-Myers Squibb Company	Method for preventing or reducing risk of onset of cardiovascular events employing an HMG CoA reductase inhibitor
IL112639A0 (en)	1994-03-11	1995-05-26	Bristol Myers Squibb Co	A pharmaceutical composition containing pravastin
US5506211A (en) *	1994-05-09	1996-04-09	The Uab Research Foundation	Genistein for use in inhibiting osteroclasts
US5424331A (en) *	1994-06-10	1995-06-13	Bio-Virus Research Incorporated	Pharmaceutical compositions and dietary soybean food products for the prevention of osteoporosis
US5547866A (en) *	1994-07-20	1996-08-20	The Regents Of The University Of California	Taxane production in haploid-derived cell cultures
DE4432947C2 (de)	1994-09-16	1998-04-09	New Standard Gmbh	Mittel zur Behandlung der Haut und seine Verwendung
AU3689095A (en)	1994-10-03	1996-04-26	Schouten Industries B.V.	Food and health products
US5516528A (en) *	1995-01-13	1996-05-14	Wake Forest University	Dietary phytoestrogen in estrogen replacement therapy
US5523087A (en) *	1995-02-15	1996-06-04	Bio-Virus Research Incorporated	Pharmaceutical compositions for the treatment of diabetic male sexual dysfunction
US5569459A (en) *	1995-02-15	1996-10-29	Bio-Virus Research Incorporated	Pharmaceutical compositions for the management of premenstrual syndrome and alleviation of menopausal disorders
US5679806A (en) *	1995-02-24	1997-10-21	Hauser, Inc.	Process for the isolation and purification of isoflavones
JPH08283283A (ja) *	1995-04-14	1996-10-29	Kikkoman Corp	マロニルイソフラボン配糖体及び該物質からイソフラボン配糖体又はイソフラボンアグリコンを取得する方法
US5639785A (en) *	1995-06-07	1997-06-17	Global Pharma, Ltd.	Methods for the treatment of baldness and gray hair using isoflavonoid derivatives
US5554519A (en) *	1995-08-07	1996-09-10	Fermalogic, Inc.	Process of preparing genistein
JPH0967362A (ja)	1995-09-01	1997-03-11	Sankyo Co Ltd	５α−還元酵素阻害剤ビスイソフラボン類
US6261565B1 (en)	1996-03-13	2001-07-17	Archer Daniels Midland Company	Method of preparing and using isoflavones
US5702752A (en) *	1996-03-13	1997-12-30	Archer Daniels Midland Company	Production of isoflavone enriched fractions from soy protein extracts
US5821361A (en)	1996-06-11	1998-10-13	Protein Technologies International, Inc.	Recovery of isoflavones from soy molasses
JPH1059956A (ja)	1996-08-22	1998-03-03	Kikkoman Corp	新規イソフラボン誘導体及びその製造法
AUPO203996A0 (en) *	1996-08-30	1996-09-26	Novogen Research Pty Ltd	Therapeutic uses
US5726034A (en) *	1996-09-06	1998-03-10	Protein Technologies International, Inc.	Aglucone isoflavone enriched vegetable protein extract and protein material, and high genistein and daidzein content materials and process for producing the same
US5804234A (en) *	1996-09-13	1998-09-08	Suh; John D.	Plant protein for nutritional products and method of making same
US5733926A (en) *	1996-12-13	1998-03-31	Gorbach; Sherwood L.	Isoflavonoids for treatment and prevention of alzheimer dementia and reduced cognitive functions
AUPO644897A0 (en)	1997-04-28	1997-05-22	Novogen Inc	Preparation of isoflavones from legumes
US6146668A (en) *	1997-04-28	2000-11-14	Novogen, Inc.	Preparation of isoflavones from legumes
AU7165798A (en)	1997-04-28	1998-11-24	Anticancer, Inc.	Use of genistein and related compounds to treat certain sex hormone related conditions
EP0979074A4 (en) *	1997-05-01	2003-07-09	Novogen Inc	TREATMENT OR PREVENTION CLIMATE ACTION SYMPTOMS AND OSTEOPOROSIS
US6083526A (en)	1997-05-22	2000-07-04	Gorbach; Sherwood L.	Use of isoflavonoids in the treatment or prevention of postpartum depression
US6060070A (en)	1997-06-11	2000-05-09	Gorbach; Sherwood L.	Isoflavonoids for treatment and prevention of aging skin and wrinkles
GT199800126A (es)	1997-08-29	2000-01-29		Terapia de combinacion.
AP1207A (en)	1997-08-29	2003-09-20	Pfizer Prod Inc	Combination therapy.
US5855892A (en) *	1997-09-19	1999-01-05	Potter; Susan M.	Method for decreasing LDL-cholesterol concentration and increasing HDL-cholesterol concentration in the blood to reduce the risk of atherosclerosis and vascular disease
US5942539A (en) *	1997-10-03	1999-08-24	Wake Forest University	Methods of treating or preventing endometriosis with phytoestrogens
FR2769502B1 (fr)	1997-10-14	2000-04-14	Sederma Sa	Compositions a usage cosmetique ou dermopharmaceutique contenant un extrait vegetal obtenu a partir du trefle (trifolium sp.)
AUPP112497A0 (en)	1997-12-24	1998-01-22	Novogen Research Pty Ltd	Compositions and method for protecting skin from UV induced immunosupression and skin damage
AU2183899A (en)	1998-01-27	1999-08-09	Shionogi & Co., Ltd.	Isoflavane derivatives and immunopotentiating compositions containing the same
AUPP198798A0 (en)	1998-02-25	1998-03-19	Novogen Research Pty Ltd	Compositions comprising extracts of isoflavone-containing plants and anti-cancer modalities involving the same
US6004558A (en) *	1998-02-25	1999-12-21	Novogen, Inc.	Methods for treating cancer with legume plant extracts
US6132795A (en)	1998-03-15	2000-10-17	Protein Technologies International, Inc.	Vegetable protein composition containing an isoflavone depleted vegetable protein material with an isoflavone containing material
BR9908870A (pt) *	1998-03-16	2000-11-21	Procter & Gamble	Processos para regularizarem a aparência da pele
AUPP260798A0 (en)	1998-03-26	1998-04-23	Novogen Research Pty Ltd	Treatment of medical related conditions with isoflavone containing extracts of clover
FR2781154B1 (fr)	1998-07-15	2001-09-07	Lafon Labor	Composition therapeutique a base d'isoflavonoides destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques
AU5440799A (en)	1998-09-17	2000-04-10	Guido Schnyder	Method and drug for the treatment of coronary heart disease and for the prevention of restenosis after percutaneous transluminal coronary angioplasty
AUPP868599A0 (en)	1999-02-15	1999-03-11	Novogen Research Pty Ltd	Production of isoflavone derivatives
US6413546B1 (en)	1999-03-18	2002-07-02	Indena, S.P.A.	Tablets incorporating isoflavone plant extracts and methods of manufacturing them
JP2002542187A (ja)	1999-04-16	2002-12-10	アストラゼネカ・アクチエボラーグ	エストロゲン−β受容体リガンド
US6544566B1 (en)	1999-04-23	2003-04-08	Protein Technologies International, Inc.	Composition containing plant sterol, soy protein and isoflavone for reducing LDL cholesterol
AUPQ008399A0 (en)	1999-04-28	1999-05-27	Novogen Research Pty Ltd	Cariovascular applications
AUPQ008299A0 (en)	1999-04-30	1999-05-27	G.J. Consultants Pty Ltd	Isoflavone metabolites
AUPQ266199A0 (en)	1999-09-06	1999-09-30	Novogen Research Pty Ltd	Compositions and therapeutic methods involving isoflavones and analogues thereof
AUPQ520300A0 (en)	2000-01-21	2000-02-17	Novogen Research Pty Ltd	Food product and process
AUPR255401A0 (en)	2001-01-16	2001-02-08	Novogen Research Pty Ltd	Regulation of lipids and/or bone density and compositions therefor
AUPR363301A0 (en)	2001-03-08	2001-04-05	Novogen Research Pty Ltd	Dimeric isoflavones
JP4256679B2 (ja)	2001-03-16	2009-04-22	ノボゲンリサーチピーティーワイリミテッド	再狭窄の治療方法

2001
- 2001-03-08 AU AUPR3633A patent/AUPR363301A0/en not_active Abandoned
2002
- 2002-03-08 HU HU0303463A patent/HUP0303463A3/hu unknown
- 2002-03-08 CZ CZ20032396A patent/CZ20032396A3/cs unknown
- 2002-03-08 EP EP02704471A patent/EP1373242A4/en not_active Withdrawn
- 2002-03-08 US US10/469,957 patent/US7312344B2/en not_active Expired - Fee Related
- 2002-03-08 WO PCT/AU2002/000264 patent/WO2002070502A1/en not_active Ceased
- 2002-03-08 NZ NZ528067A patent/NZ528067A/en unknown
- 2002-03-08 BR BR0208053-2A patent/BR0208053A/pt not_active IP Right Cessation
- 2002-03-08 CN CNB028090195A patent/CN100436439C/zh not_active Expired - Fee Related
- 2002-03-08 JP JP2002569822A patent/JP2004529900A/ja active Pending
- 2002-03-08 CA CA002440642A patent/CA2440642A1/en not_active Abandoned
- 2002-03-08 MX MXPA03008076A patent/MXPA03008076A/es active IP Right Grant
- 2002-03-08 IL IL15775002A patent/IL157750A0/xx unknown
2003
- 2003-09-03 NO NO20033898A patent/NO20033898L/no not_active Application Discontinuation
- 2003-09-04 IL IL157750A patent/IL157750A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
NO20033898D0 (no)	2003-09-03
HK1066797A1 (zh)	2005-04-01
CN1505618A (zh)	2004-06-16
CN100436439C (zh)	2008-11-26
BR0208053A (pt)	2004-02-25
HUP0303463A3 (en)	2005-02-28
IL157750A (en)	2009-08-03
IL157750A0 (en)	2004-03-28
EP1373242A1 (en)	2004-01-02
MXPA03008076A (es)	2004-03-16
EP1373242A4 (en)	2005-08-24
WO2002070502A1 (en)	2002-09-12
CZ20032396A3 (cs)	2004-02-18
AUPR363301A0 (en)	2001-04-05
HUP0303463A1 (hu)	2004-01-28
NZ528067A (en)	2005-09-30
US20040152761A1 (en)	2004-08-05
JP2004529900A (ja)	2004-09-30
CA2440642A1 (en)	2002-09-12
US7312344B2 (en)	2007-12-25

Legal Events

Date	Code	Title	Description
2010-04-06	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
ATE319451T1 (de)	2006-03-15	Tetrahydrochinolin-derivate
DE60208775D1 (de)	2006-04-06	Formgedächtnisstyrolcopolymer
DE60230521D1 (de)	2009-02-05	Fluiddruckreduzierventil
ATE312827T1 (de)	2005-12-15	3-substituierte-4-pyrimidonderivate
DE60227724D1 (de)	2008-08-28	Spülrohranordnung
DE60227131D1 (de)	2008-07-31	Navigationssytem
DE60116518D1 (de)	2006-03-30	Mehrzweckbohrwagen
DK1361880T3 (da)	2006-01-23	6-substituerede pyrido-pyrimidiner
DE60223682D1 (de)	2008-01-03	Tintenstrahldrucktintenset
EP1440774A4 (en)	2006-05-31	BIOFUEL HUMANOID ROBOT
EP1394038A4 (en)	2009-05-13	AIRSHIP
DE50208022D1 (de)	2006-10-12	Wischblatt
DE50204386D1 (de)	2006-02-09	Kreuztransducer
DE60228157D1 (de)	2008-09-25	Berstschutzvorrichtung
NO20033898L (no)	2003-10-30	Dimeriske isoflavoner
DE60201341D1 (de)	2004-10-28	Hochbahn
DE50204551D1 (de)	2005-11-17	Kugelgelenk
DE50211604D1 (de)	2008-03-13	Chlag
DE60232493D1 (de)	2009-07-16	Tikgetriebes
DE60112475D1 (de)	2005-09-08	Einschraubenverdichter
DE50203412D1 (de)	2005-07-21	Schwenkkolbenverdränger
DE60219393D1 (de)	2007-05-24	Kraftfahrzeugkarrosseriestruktur
DE50203984D1 (de)	2005-09-22	Kugelgelenk
DE60214306D1 (de)	2006-10-12	Schwimbrille
DE60223031D1 (de)	2007-11-29	Arylpiperazin gebundene tetrahydroindolonderivate